Oral Bioavailability of Two Solid Formulations of GLPG0634

计划入组 12 人 · 首次发布于 2013 年 8 月 5 日

Oral Bioavailability of Two Solid Formulations of GLPG0259.

计划入组 12 人 · 首次发布于 2011 年 3 月 24 日

A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formulations

计划入组 16 人 · 首次发布于 2025 年 5 月 30 日

cannaboside formulations

CLK3 inhibitor (oral, solid tumors), Biosplice Therapeutics

CLK2 inhibitor (oral, solid tumors), Biosplice Therapeutics

Yichang Humanwell Oral Solid Dosage Plant

China

Solid Biosciences Inc.

United States

PAR FORMULATIONS PRIVATE LIMITED

India

Conduit Pharmaceuticals Teams with Agility Life Sciences to Advance Autoimmune Drug Formulations

Tilray Medical Publishes Pharmacokinetic Study Comparing Oral and Oromucosal Cannabis Formulations

Alembic Pharma Shares Surge Following USFDA Clearance of Panelav Oncology Facility